When I was talking to a breast surgeon today, he shared with me his experience of my drug, and also my competitor's drug.
He said he has a patient recently who came in as stage 4 breast cancer patient Very severe, he said he once thought it was a "no hope" patient. He referred the patient to an oncologist and together they started treating her with chemotherapy as well as my drug - Hxx.
He said after sometimes patient progressed from the disease. Hxx at that point of time did not seem to help her in controlling the disease in spreading further. Then the oncologist proceed on next line of treatment, to use Txx, which is indicated for 2nd line treatment after progression of Hxx.
Luckily for the patient, Txx seems to work on her. She seems to tolerate well with the drug and now she is doing okay, at least not as ill as before. The breast surgeon said he is convinced. I mean, totally convinced.
As a sales person who is selling Hxx, by right I should defend for my drug, probably list down 101 reasons why Hxx may not work. But I didn't, I look at the surgeon and nodded. I am glad that the patient has found a drug that can help her, and I believe regardless of how competitive the market is, every drug has its role, and has its positioning in the market, especially in the oncology market.
Txx is indicated to use after Hxx in HER2+ advanced breast cancer who spread to other sites and organs. I think the oncologist has made the right decision, and I guess this will be the future direction of pharmaceutical sales. We market and promote our products based on positioning. Every drug has it roles at different stages of the disease, and we are here to save patients lives, not to take them away for the sake of our sales.
P/S: This is just my opinion. If you do not agree, just have a good laugh and forget about it. Cheers!
He said he has a patient recently who came in as stage 4 breast cancer patient Very severe, he said he once thought it was a "no hope" patient. He referred the patient to an oncologist and together they started treating her with chemotherapy as well as my drug - Hxx.
He said after sometimes patient progressed from the disease. Hxx at that point of time did not seem to help her in controlling the disease in spreading further. Then the oncologist proceed on next line of treatment, to use Txx, which is indicated for 2nd line treatment after progression of Hxx.
Luckily for the patient, Txx seems to work on her. She seems to tolerate well with the drug and now she is doing okay, at least not as ill as before. The breast surgeon said he is convinced. I mean, totally convinced.
As a sales person who is selling Hxx, by right I should defend for my drug, probably list down 101 reasons why Hxx may not work. But I didn't, I look at the surgeon and nodded. I am glad that the patient has found a drug that can help her, and I believe regardless of how competitive the market is, every drug has its role, and has its positioning in the market, especially in the oncology market.
Txx is indicated to use after Hxx in HER2+ advanced breast cancer who spread to other sites and organs. I think the oncologist has made the right decision, and I guess this will be the future direction of pharmaceutical sales. We market and promote our products based on positioning. Every drug has it roles at different stages of the disease, and we are here to save patients lives, not to take them away for the sake of our sales.
P/S: This is just my opinion. If you do not agree, just have a good laugh and forget about it. Cheers!
No comments:
Post a Comment